RecruitingNot ApplicableNCT05260268

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Sponsor

University of Pennsylvania

Enrollment

360 participants

Start Date

Dec 1, 2022

Study Type

INTERVENTIONAL

Conditions

Cirrhosis Liver Transplant; Complications End Stage Liver Disease Medication Adherence

Summary

Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called TEST Intervention for people with cirrhosis, end stage liver disease, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTEST Intervention

The TEST intervention will include standard post-transplant care and include additional touchpoints utilizing the Way to Health system. Details on this intervention are included in the study arm description.